Developer docs
API playgroundTry for free, no card

Search company profiles

Plasma Services Group

Full company profile

uuid000bwma

Namestring
Plasma Services Group
Legal namestring
Plasma Services Group, Inc.
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Plasma Services Group, Inc. (PSG) is a Moorestown, New Jersey-based specialty biological materials supplier and clinical laboratory serving the in vitro diagnostics (IVD) and life sciences industries. The company's core function is the collection, screening, processing, storage, and distribution of disease-state plasma — human plasma from donors with specifically characterized antibody profiles — used by IVD manufacturers for assay development, quality control, and kit manufacturing. PSG maintains an inventory of more than 1,500 serologically defined plasma units covering 60+ antibody specificities and screens 75-100 donors monthly for up to 25 diseases through a two-fold prospective and active donor recruitment model. Complementary offerings include custom plasma processing (defibrination, delipidization, pooling), biobanking of pre-qualified units, validation and clinical sample panels, and full-service clinical laboratory testing in immunology, hematology, microbiology, and molecular diagnostics performed by ASCP-certified Medical Technologists.

PSG operates a hybrid revenue model across five streams: (1) B2B disease-state plasma and processed/custom plasma sales to IVD manufacturers and research organizations on a quote-based, per-unit basis; (2) clinical laboratory testing services billed as professional services to support clinical trials, validation, beta testing, and safety advisory work; (3) exclusive distribution of IUIS Autoantibody Standardization Committee reference standards (in cooperation with the CDC) for autoantibody specificity testing; (4) direct-to-consumer health screening packages (Basic Care $90, Essential Care $190, Total Care $290); and (5) donor-side compensation economics (donors receive $200 per future donation) that underwrites the supply side of the plasma funnel. Distribution runs primarily through a small direct sales team (Nichelle Porto, Kate Boylan, Tony Zamparelli, Kathryn Kohl) contacting enterprise IVD buyers by phone and email, supplemented by conference presence (AACC, AMLI, MEDICA, International Congress on Autoimmunity) and a B2C donor/consumer website (PSGDonors.com).

Regulatory and quality positioning is central to PSG's value proposition: the company holds FDA Blood Establishment Registration (number 300527238), ISO 9001:2015 certification, and compliance with US FDA 21 CFR §820 Quality System Regulations — credentials that, per company materials, only a handful of US donor centers can match for legally bleeding donors with clinically identified disease states. The company was founded in 2004 by Jeffrey Fleishman, transitioned to majority ownership by Katherine Boylan and Nichelle Fernandez in 2018-2021, and was acquired by Fujirebio Holdings, Inc. (a Japanese diagnostics company) in June 2025, under which PSG now operates as a wholly-owned subsidiary.

Short descriptiontext

Plasma Services Group is a Moorestown, NJ-based specialty biological materials supplier that collects, screens, processes, and distributes disease-state and reference plasma to in vitro diagnostic manufacturers, clinical research organizations, and individual consumers for assay development, validation, and health screening.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMoorestown, United States
HQ citystring
Moorestown
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty biological materials, disease state plasma, IVD raw materials, clinical laboratory testing, autoantibody reference standards
Industry3 codes
PRIMARYHLAIAHAH
Plasma Collection & Donor Services (Plasmapheresis Centers)
SECONDARYHLAIAJAJ
Plasma-Derived & Blood Products Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAHAAAH
Blood Bank, Transfusion Medicine & Immunohematology
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code3 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Medical Laboratories621511
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers423450
SIC code3 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Medical Laboratories8071
  • Biological Products, (No Disgnostic Substances)2836
Product category
Specialty Biological Materials and Diagnostics Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Disease State Plasma Sales
TypeOne Time License
Description

Sale of specialty plasma collected from donors with specific disease conditions. PSG stocks over 1500 units of serologically defined plasma with over 60 different specificities. Materials include serologically defined bleeds, disease state plasma, and custom products collected/processed to customer specifications.

plasmaservicesgroup.com
2Laboratory Testing Services
TypeProfessional Services
Description

Clinical laboratory services including immunology, hematology, microbiology, and molecular diagnostics testing. Services support clinical trials, validation and beta testing, and safety advisory services.

plasmaservicesgroup.com
3Plasma Processing Services
TypeProfessional Services
Description

Custom processing of materials to customer specifications including defibrination, delipidization, and pooling. Also includes storage and inventorying of pre-qualified units.

plasmaservicesgroup.com
4Reference Standards Distribution
TypeOne Time License
Description

Distribution of IUIS-ANA reference standards for autoantibody specificities through PSG, in cooperation with CDC. Availability limited to 1 vial of each ANA reference per laboratory.

plasmaservicesgroup.com
5Health Check Packages
TypeOne Time License
Description

Direct-to-consumer health screening packages including Basic Care ($90), Essential Care ($190), and Total Care ($290).

plasmaservicesgroup.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D
Pricing details5 tiers
1Donor Compensation
ModelOtherBilling cadencePer donation
Notes

Eligible donors are compensated $200 for every future donation at their site. This is a compensation model for plasma donors rather than customer pricing.

plasmaservicesgroup.com
2Basic Care Health Check - $90
ModelUnit PricingBilling cadenceOne time
Notes

Complete Blood Count, Liver Function Blood Test, Heart Disease Blood Tests, Cholesterol/Lipid Levels, Sexually Transmitted Diseases, Male/Female General Health Panel, Comprehensive Metabolic Panel

plasmaservicesgroup.com
3Essential Care Health Check - $190
ModelUnit PricingBilling cadenceOne time
Notes

Gold Health Check including Complete Blood Count

plasmaservicesgroup.com
4Total Care Health Check - $290
ModelUnit PricingBilling cadenceOne time
Notes

Platinum Health Check including Complete Blood Count

plasmaservicesgroup.com
5B2B Plasma and Services - Quote-based
ModelOtherBilling cadencePay-as-you-go
Notes

0.5ml samples provided free of charge for customer evaluation. B2B pricing requires contacting sales team. 14-day return policy for plasma purchases. Company offers buy-back program for unused disease state plasma stored frozen and not adulterated.

plasmaservicesgroup.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Plasma Services Group collects, processes, stores, and distributes human plasma with specific antibody profiles (disease state plasma) for use by in vitro diagnostic (IVD) manufacturers and research institutions in diagnostic kit development, quality control, and manufacturing. The company also provides custom plasma processing services (defibrination, delipidization, pooling), full-service clinical laboratory testing across immunology, hematology, microbiology, and molecular diagnostics, exclusive distribution of IUIS-ANA reference standards in cooperation with CDC, and direct-to-consumer health screening packages.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Over 1,500 units of serologically defined plasma available with 60+ specificities
+1 more record
Product overview1 text field

Plasma Services Group operates as a medical and research diagnostics company offering a portfolio of biological materials and laboratory services for the IVD industry. The core product is Disease State Plasma — serologically defined plasma from donors with specific conditions — supplemented by Validation and Clinical Sample Panels and IUIS-ANA Reference Standards for autoantibody testing. These biological materials are complemented by Plasma Processing Services (defibrination, delipidization, pooling) and BioBanking Services for storage and inventory management. The company also provides Clinical Laboratory Testing Services across immunology, hematology, microbiology, and molecular diagnostics, plus Health Check Packages for diagnostic screening. In June 2025, Plasma Services Group was acquired by Fujirebio Holdings, Inc. to strengthen its biological raw materials supply for the IVD and life science industries.

Product and service9 records
1Disease State Plasma
CategorySpecialty biological materials / Core product
Description

Serologically defined plasma collected from donors with specific diseases, used in R&D, quality control, and manufacturing within the IVD industry. PSG maintains an inventory of over 1,500 units spanning 60+ antibody specificities.

2Validation and Clinical Sample Panels
CategorySpecialty biological materials / Core product
Description

Pre-qualified plasma units used for assay validation and clinical testing purposes by IVD manufacturers.

3IUIS-ANA Reference Standards
CategorySpecialty biological materials / Core product
Description

Reference standards for autoantibody specificities, distributed exclusively through PSG in cooperation with the IUIS Autoantibody Standardization Committee and the CDC. Includes anti-mitochondrial and anti-rods/rings autoantibodies. Availability limited to 1 vial per laboratory.

4Plasma Processing Services
CategorySpecialty services
Description

Custom processing including defibrination, delipidization, and pooling materials to customer specifications, with storage and inventorying of pre-qualified units.

5Clinical Laboratory Testing Services
CategoryClinical laboratory services
Description

Full-service laboratory offering immunology, hematology, microbiology, and molecular diagnostics testing for clinical trials, validation and beta testing, and safety advisory services. Performed by ASCP-certified Medical Technologists.

6Health Check Packages
CategoryDirect-to-consumer health screening services
Description

Tiered health screening packages for individual consumers including Basic Care ($90) for complete blood count, liver function, heart disease, cholesterol/lipid, STD, and metabolic panels; Essential Care ($190) Gold Health Check with CBC; and Total Care ($290) Platinum Health Check with CBC.

7Research Testing for Clinical Trials
CategoryClinical research services
Description

Laboratory testing services supporting clinical trials with assay validation and beta testing capabilities for research institutions and CROs.

8BioBanking Services
CategoryBiobanking / Storage services
Description

Storage and inventory management of pre-qualified plasma units for future purchase at no additional cost.

9Donor Screening Services
CategorySpecialty donor screening services
Description

Screening of donors in customer-specific test kits to identify and qualify specialty plasma donors. PSG screens 75-100 donors per month for up to 25 different diseases.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1Fujirebio Holdings, Inc.
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-06-20
Description

Fujirebio Holdings, Inc. acquired Plasma Services Group in June 2025. The acquisition aims to create synergies by combining biological materials and samples, strengthening Fujirebio's position as a provider of biological raw materials to the IVD and life science industries. Plasma Services Group now operates as a subsidiary of Fujirebio.

straitsresearch.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic business relationship established to distribute American Red Cross viral and syphilis marker deferred plasma units. This partnership enhances PSG's product offerings by providing access to additional plasma sources.

3IUIS Autoantibody Standardization Committee (ASC)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

PSG serves as the exclusive distributor for IUIS Autoantibody Standardization Committee reference standards for autoantibody specificities. The ASC, in cooperation with the Centers for Disease Control (CDC) USA, makes reference standards available through PSG. In addition to the 17 reference reagents previously available from CDC, PSG generates and distributes new reference reagents including anti-mitochondrial and anti-rods/rings autoantibodies.

plasmaservicesgroup.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CDC cooperates with the IUIS Autoantibody Standardization Committee to make reference standards available through PSG. PSG distributes reference reagents previously available from CDC, with new reagents being generated and distributed by PSG.

Strategic tierMinorTypeOthers
Description

NovaLab provides laboratory testing services referenced on PSG's services page. The relationship appears to be a service provider partnership for clinical laboratory testing including immunology, hematology, and microbiology services.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global plasma collection and plasma-derived therapeutics leader operating hundreds of donor centers. Comparable as a large-scale plasma collector, though Grifols focuses on therapeutic fractionation rather than IVD-specific disease-state plasma.

TypeBroad incumbent
Description

Major plasma collection and fractionation company through its parent CSL Limited. Overlaps with PSG in plasma sourcing infrastructure but targets therapeutic end markets at much larger scale.

TypeBroad incumbent
Description

Privately held plasma fractionator with donor centers across the US and Europe. Comparable as a plasma collector for human plasma-derived products, though focused on therapeutic proteins rather than IVD raw materials.

4SeraCare (LGC Clinical Diagnostics)
TypeDirect peer
Description

Provider of biological materials, reference standards, and controls for the IVD and life-science industries. Closely matches PSG's specialty biological-materials and reference-standard distribution model for diagnostic manufacturers.

5HemaCare (Charles River Laboratories)
TypeDirect peer
Description

Supplier of human-derived biological products including disease-state plasma and apheresis collections for research and IVD use. Now part of Charles River, offering comparable specialty plasma and cellular materials.

TypeBroad incumbent
Description

Major IVD manufacturer and supplier of quality controls, reference materials, and immunoassay reagents. Comparable as a buyer and competitor in the IVD materials ecosystem, particularly for autoimmune diagnostics.

TypeDirect peer
Description

Specialty diagnostics company focused on transfusion and transplant immunology, sourcing rare antibody-positive blood products. Overlaps with PSG in donor-sourced specialty biologicals for the diagnostics industry.

TypeRegional player
Description

Privately held French specialty diagnostics company focused on hemostasis and coagulation testing. Comparable as a specialty IVD player with related autoimmune/coagulation reagent portfolios, though more regionally focused on Europe.

TypeEmerging player
Description

Specialty supplier of human plasma and serum products for IVD manufacturers, including disease-state and normal donor materials. Comparable as a niche peer in disease-state plasma sourcing for diagnostic kit developers.

TypeEmerging player
Description

Supplier of human biological samples including plasma and serum for research and diagnostics applications. Comparable as a small specialty biological-materials supplier to IVD and life-science customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Plasma Services Group

Specialty Biological Materials and Diagnostics Servicesplasmaservicesgroup.com

Plasma Services Group is a Moorestown, NJ-based specialty biological materials supplier that collects, screens, processes, and distributes disease-state and reference plasma to in vitro diagnostic manufacturers, clinical research organizations, and individual consumers for assay development, validation, and health screening.

What Plasma Services Group does

Plasma Services Group, Inc. (PSG) is a Moorestown, New Jersey-based specialty biological materials supplier and clinical laboratory serving the in vitro diagnostics (IVD) and life sciences industries. The company's core function is the collection, screening, processing, storage, and distribution of disease-state plasma — human plasma from donors with specifically characterized antibody profiles — used by IVD manufacturers for assay development, quality control, and kit manufacturing. PSG maintains an inventory of more than 1,500 serologically defined plasma units covering 60+ antibody specificities and screens 75-100 donors monthly for up to 25 diseases through a two-fold prospective and active donor recruitment model. Complementary offerings include custom plasma processing (defibrination, delipidization, pooling), biobanking of pre-qualified units, validation and clinical sample panels, and full-service clinical laboratory testing in immunology, hematology, microbiology, and molecular diagnostics performed by ASCP-certified Medical Technologists.

PSG operates a hybrid revenue model across five streams: (1) B2B disease-state plasma and processed/custom plasma sales to IVD manufacturers and research organizations on a quote-based, per-unit basis; (2) clinical laboratory testing services billed as professional services to support clinical trials, validation, beta testing, and safety advisory work; (3) exclusive distribution of IUIS Autoantibody Standardization Committee reference standards (in cooperation with the CDC) for autoantibody specificity testing; (4) direct-to-consumer health screening packages (Basic Care $90, Essential Care $190, Total Care $290); and (5) donor-side compensation economics (donors receive $200 per future donation) that underwrites the supply side of the plasma funnel. Distribution runs primarily through a small direct sales team (Nichelle Porto, Kate Boylan, Tony Zamparelli, Kathryn Kohl) contacting enterprise IVD buyers by phone and email, supplemented by conference presence (AACC, AMLI, MEDICA, International Congress on Autoimmunity) and a B2C donor/consumer website (PSGDonors.com).

Regulatory and quality positioning is central to PSG's value proposition: the company holds FDA Blood Establishment Registration (number 300527238), ISO 9001:2015 certification, and compliance with US FDA 21 CFR §820 Quality System Regulations — credentials that, per company materials, only a handful of US donor centers can match for legally bleeding donors with clinically identified disease states. The company was founded in 2004 by Jeffrey Fleishman, transitioned to majority ownership by Katherine Boylan and Nichelle Fernandez in 2018-2021, and was acquired by Fujirebio Holdings, Inc. (a Japanese diagnostics company) in June 2025, under which PSG now operates as a wholly-owned subsidiary.

Plasma Services Group firmographics

Firmographics
Name
Plasma Services Group
Legal name
Plasma Services Group, Inc.
Website
https://plasmaservicesgroup.com
Company type
Private
Founded year
2004
Operating status
Acquired
Headcount range
11–50 employees
Short description
Plasma Services Group is a Moorestown, NJ-based specialty biological materials supplier that collects, screens, processes, and distributes disease-state and reference plasma to in vitro diagnostic manufacturers, clinical research organizations, and individual consumers for assay development, validation, and health screening.
Ownership category
akta.pro rank

Plasma Services Group industry classification

Industry
Product category
Specialty Biological Materials and Diagnostics Services
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAIAHAH
Plasma Collection & Donor Services (Plasmapheresis Centers)
SECONDARYHLAIAJAJ
Plasma-Derived & Blood Products Distributors
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling
SECONDARYHLAHAAAH
Blood Bank, Transfusion Medicine & Immunohematology
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • Specialty biological materials
  • Disease state plasma
  • IVD raw materials
  • Clinical laboratory testing
  • Autoantibody reference standards

Where Plasma Services Group is headquartered

Location

Headquarters

HQ city
Moorestown
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Plasma Services Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

  1. Disease State Plasma Sales: Sale of specialty plasma collected from donors with specific disease conditions. PSG stocks over 1500 units of serologically defined plasma with over 60 different specificities. Materials include serologically defined bleeds, disease state plasma, and custom products collected/processed to customer specifications.
  2. Laboratory Testing Services: Clinical laboratory services including immunology, hematology, microbiology, and molecular diagnostics testing. Services support clinical trials, validation and beta testing, and safety advisory services.
  3. Plasma Processing Services: Custom processing of materials to customer specifications including defibrination, delipidization, and pooling. Also includes storage and inventorying of pre-qualified units.
  4. Reference Standards Distribution: Distribution of IUIS-ANA reference standards for autoantibody specificities through PSG, in cooperation with CDC. Availability limited to 1 vial of each ANA reference per laboratory.
  5. Health Check Packages: Direct-to-consumer health screening packages including Basic Care ($90), Essential Care ($190), and Total Care ($290).

Pricing tiers

ModelBillingPrice
OtherPer donationDonor Compensation
Unit PricingOne timeBasic Care Health Check - $90
Unit PricingOne timeEssential Care Health Check - $190
Unit PricingOne timeTotal Care Health Check - $290
OtherPay-as-you-goB2B Plasma and Services - Quote-based

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Plasma Services Group product offering

Product offering

Core offering

Plasma Services Group collects, processes, stores, and distributes human plasma with specific antibody profiles (disease state plasma) for use by in vitro diagnostic (IVD) manufacturers and research institutions in diagnostic kit development, quality control, and manufacturing. The company also provides custom plasma processing services (defibrination, delipidization, pooling), full-service clinical laboratory testing across immunology, hematology, microbiology, and molecular diagnostics, exclusive distribution of IUIS-ANA reference standards in cooperation with CDC, and direct-to-consumer health screening packages.

Product overview

Plasma Services Group operates as a medical and research diagnostics company offering a portfolio of biological materials and laboratory services for the IVD industry. The core product is Disease State Plasma — serologically defined plasma from donors with specific conditions — supplemented by Validation and Clinical Sample Panels and IUIS-ANA Reference Standards for autoantibody testing. These biological materials are complemented by Plasma Processing Services (defibrination, delipidization, pooling) and BioBanking Services for storage and inventory management. The company also provides Clinical Laboratory Testing Services across immunology, hematology, microbiology, and molecular diagnostics, plus Health Check Packages for diagnostic screening. In June 2025, Plasma Services Group was acquired by Fujirebio Holdings, Inc. to strengthen its biological raw materials supply for the IVD and life science industries.

Differentiator

Problem solved

Functional benefit

Products and services

  • Disease State Plasma Serologically defined plasma collected from donors with specific diseases, used in R&D, quality control, and manufacturing within the IVD industry. PSG maintains an inventory of over 1,500 units spanning 60+ antibody specificities.
  • Validation and Clinical Sample Panels Pre-qualified plasma units used for assay validation and clinical testing purposes by IVD manufacturers.
  • IUIS-ANA Reference Standards Reference standards for autoantibody specificities, distributed exclusively through PSG in cooperation with the IUIS Autoantibody Standardization Committee and the CDC. Includes anti-mitochondrial and anti-rods/rings autoantibodies. Availability limited to 1 vial per laboratory.
  • Plasma Processing Services Custom processing including defibrination, delipidization, and pooling materials to customer specifications, with storage and inventorying of pre-qualified units.
  • Clinical Laboratory Testing Services Full-service laboratory offering immunology, hematology, microbiology, and molecular diagnostics testing for clinical trials, validation and beta testing, and safety advisory services. Performed by ASCP-certified Medical Technologists.
  • Health Check Packages Tiered health screening packages for individual consumers including Basic Care ($90) for complete blood count, liver function, heart disease, cholesterol/lipid, STD, and metabolic panels; Essential Care ($190) Gold Health Check with CBC; and Total Care ($290) Platinum Health Check with CBC.
  • Research Testing for Clinical Trials Laboratory testing services supporting clinical trials with assay validation and beta testing capabilities for research institutions and CROs.
  • BioBanking Services Storage and inventory management of pre-qualified plasma units for future purchase at no additional cost.
  • Donor Screening Services Screening of donors in customer-specific test kits to identify and qualify specialty plasma donors. PSG screens 75-100 donors per month for up to 25 different diseases.

Quantifiable outcome

  • Over 1,500 units of serologically defined plasma available with 60+ specificities
  • +1 more outcomes

Companies that use Plasma Services Group

Customer profile

Named customers3 records

Segments5 records

Ideal customer profiles3 records

Plasma Services Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Plasma Services Group partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Fujirebio Holdings, Inc.coreStrategic or Co-development Partner · 20 June 2025Fujirebio Holdings, Inc. acquired Plasma Services Group in June 2025. The acquisition aims to create synergies by combining biological materials and samples, strengthening Fujirebio's position as a provider of biological raw materials to the IVD and life science industries. Plasma Services Group now operates as a subsidiary of Fujirebio.
  • American Red CrosscoreStrategic or Co-development PartnerStrategic business relationship established to distribute American Red Cross viral and syphilis marker deferred plasma units. This partnership enhances PSG's product offerings by providing access to additional plasma sources.
  • IUIS Autoantibody Standardization Committee (ASC)coreStrategic or Co-development PartnerPSG serves as the exclusive distributor for IUIS Autoantibody Standardization Committee reference standards for autoantibody specificities. The ASC, in cooperation with the Centers for Disease Control (CDC) USA, makes reference standards available through PSG. In addition to the 17 reference reagents previously available from CDC, PSG generates and distributes new reference reagents including anti-mitochondrial and anti-rods/rings autoantibodies.
  • Centers for Disease Control and Prevention (CDC)coreStrategic or Co-development PartnerCDC cooperates with the IUIS Autoantibody Standardization Committee to make reference standards available through PSG. PSG distributes reference reagents previously available from CDC, with new reagents being generated and distributed by PSG.
  • Novalab (NovaLab)minorOthersNovaLab provides laboratory testing services referenced on PSG's services page. The relationship appears to be a service provider partnership for clinical laboratory testing including immunology, hematology, and microbiology services.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Plasma Services Group competitors and assessment

Company assessment

Broad incumbents

  • Grifols: Global plasma collection and plasma-derived therapeutics leader operating hundreds of donor centers. Comparable as a large-scale plasma collector, though Grifols focuses on therapeutic fractionation rather than IVD-specific disease-state plasma.
  • CSL Behring: Major plasma collection and fractionation company through its parent CSL Limited. Overlaps with PSG in plasma sourcing infrastructure but targets therapeutic end markets at much larger scale.
  • Octapharma: Privately held plasma fractionator with donor centers across the US and Europe. Comparable as a plasma collector for human plasma-derived products, though focused on therapeutic proteins rather than IVD raw materials.
  • Bio-Rad Laboratories: Major IVD manufacturer and supplier of quality controls, reference materials, and immunoassay reagents. Comparable as a buyer and competitor in the IVD materials ecosystem, particularly for autoimmune diagnostics.

Direct peers

  • SeraCare (LGC Clinical Diagnostics): Provider of biological materials, reference standards, and controls for the IVD and life-science industries. Closely matches PSG's specialty biological-materials and reference-standard distribution model for diagnostic manufacturers.
  • HemaCare (Charles River Laboratories): Supplier of human-derived biological products including disease-state plasma and apheresis collections for research and IVD use. Now part of Charles River, offering comparable specialty plasma and cellular materials.
  • Immucor: Specialty diagnostics company focused on transfusion and transplant immunology, sourcing rare antibody-positive blood products. Overlaps with PSG in donor-sourced specialty biologicals for the diagnostics industry.

Regional players

  • Diagnostica Stago: Privately held French specialty diagnostics company focused on hemostasis and coagulation testing. Comparable as a specialty IVD player with related autoimmune/coagulation reagent portfolios, though more regionally focused on Europe.

Emerging players

  • Trina Bioreactives: Specialty supplier of human plasma and serum products for IVD manufacturers, including disease-state and normal donor materials. Comparable as a niche peer in disease-state plasma sourcing for diagnostic kit developers.
  • ZenBio: Supplier of human biological samples including plasma and serum for research and diagnostics applications. Comparable as a small specialty biological-materials supplier to IVD and life-science customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Plasma Services Group social profiles

Digital presence

Plasma Services Group compliance and trust

Trust signal

Compliance3 records

Plasma Services Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Plasma Services Group leadership team

Management profile

Number of profiles

Profiles4 records

Plasma Services Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Plasma Services Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Plasma Services Group

What does Plasma Services Group do?

Plasma Services Group collects, processes, stores, and distributes human plasma with specific antibody profiles (disease state plasma) for use by in vitro diagnostic (IVD) manufacturers and research institutions in diagnostic kit development, quality control, and manufacturing. The company also provides custom plasma processing services (defibrination, delipidization, pooling), full-service clinical laboratory testing across immunology, hematology, microbiology, and molecular diagnostics, exclusive distribution of IUIS-ANA reference standards in cooperation with CDC, and direct-to-consumer health screening packages.

Is Plasma Services Group a public or private company?

Plasma Services Group is a private company. It is classified as corporate owned and is currently acquired.

When was Plasma Services Group founded?

Plasma Services Group was founded in 2004. It employs 11 to 50 people.

Where is Plasma Services Group based?

Plasma Services Group is headquartered in Moorestown, United States, in the North America region.

How does Plasma Services Group make money?

Five revenue lines are on record. Disease State Plasma Sales are the primary driver. The others are laboratory Testing Services, plasma Processing Services, reference Standards Distribution and health Check Packages.

Who are Plasma Services Group's main competitors?

Broad incumbents on record are Grifols, CSL Behring, Octapharma and Bio-Rad Laboratories. Direct peers are SeraCare (LGC Clinical Diagnostics), HemaCare (Charles River Laboratories) and Immucor. Diagnostica Stago is listed as a regional player. Emerging players are Trina Bioreactives and ZenBio.

Does Plasma Services Group have an API?

No public API is recorded for Plasma Services Group.

What industry is Plasma Services Group in?

Plasma Services Group's product category is Specialty Biological Materials and Diagnostics Services. Its primary akta.pro industry code is HLAIAHAH, Plasma Collection & Donor Services (Plasmapheresis Centers), with a secondary code of HLAIAJAJ, Plasma-Derived & Blood Products Distributors. Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AETOSWireFujirebio Acquires Plasma Services Group and Strengthens Its Position as Provider of Critical and High Quality Biological Raw Materials to the IVD and Life Science IndustriesFujirebio Diagnostics acquired all shares of Plasma Services Group, a provider of rare biological materials for IVD and life science. The transaction value was not disclosed. The acquisition aims to strengthen Fujirebio's position as a CDMO partner.GlobeNewswireIVD Raw Materials Market Report Just Released — Forecasts Expansion from $30.16B in 2026 to $43.76B in 2030ResearchAndMarkets.com released the IVD Raw Materials Market Report 2026, projecting the market to grow from $27.47 billion in 2025 to $30.16 billion in 2026 and $43.76 billion by 2030, at a compound annual growth rate of 9.8%. Two notable company developments were reported: Colexa Biosensor Limited and Codix Pharma Limited opened Sub-Saharan Africa's first IVD manufacturing facility in Lagos with an initial annual capacity of 3.6 million packs, while Fujirebio Holdings, Inc. acquired Plasma Services Group, Inc. to strengthen its supply chain of biological raw materials.UAE ReviewFujirebio Acquires Plasma Services Group and Strengthens Its Position as Provider of Critical and High Quality Biological Raw Materials to the IVD and Life Science IndustriesFujirebio Diagnostics, Inc., a subsidiary of Fujirebio, has acquired all shares of Plasma Services Group, Inc., a specialist in the collection, screening and supply of high-quality biological raw materials for the in vitro diagnostics (IVD) and life science industries. The transaction value was not disclosed. Founded in 2004, Plasma Services Group operates from an FDA-registered, ISO-certified facility in Moorestown, New Jersey, and provides sera and other samples for control reagents and calibrators, with particular expertise in rare diseases.Houlihan Lokey (HL)Fujirebio - Plasma Services GroupFujirebio Holdings, Inc. has acquired Plasma Services Group, Inc. (PSG), with the transaction closing on June 20, 2025. PSG, founded in 2004, operates an FDA-registered, ISO-certified facility in Moorestown, New Jersey, specializing in the collection, screening, and supply of high-quality biological materials for the in vitro diagnostics (IVD) and life science industries. Through this acquisition, Fujirebio expects to generate synergies by combining its rare samples and biological materials offering, reinforcing its position as a contract development and manufacturing organization (CDMO) partner.